The current work provides evidence that the USP22 deubiquitinase, part of the DUBm of the SAGA complex, supports the mitochondrial biogenesis transcriptomic program to foster the CSC traits and promote the drug resistant features of HER2+-BC and TNBC cells (Fig. 7). Here, USP22 is linked to breast cancer.